default author photo

Jennifer Serwanga

London School of Hygiene & Tropical Medicine - Uganda Research Unit

SCHOLARLY PAPERS

8

DOWNLOADS

525

TOTAL CITATIONS

3

Scholarly Papers (8)

1.

Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa

Number of pages: 24 Posted: 26 Mar 2024
Center for Family Health Research Zambia (CFHRZ), Government of Uganda - Uganda Virus Research Institute (UVRI), University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Oxford, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, University of Oxford, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), IAVI, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of Oxford, IAVI, Imperial College London - IAVI Human Immunology Laboratory, London School of Hygiene & Tropical Medicine - Uganda Research Unit, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, affiliation not provided to SSRN, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), affiliation not provided to SSRN, Center for Family Health Research Zambia (CFHRZ), MRC/UVRI & LSHTM Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, International AIDS Vaccine Initiative, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, University of Nairobi, IAVI, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, Oxus Technologies Limited, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Nairobi, University of Nairobi, UVRI-IAVI HIV Vaccine Program, University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of California, San Francisco (UCSF) - Department of Medicine, IAVI, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Oxford, Imperial College London - IAVI Human Immunology Laboratory, University of Oxford - Oxford Vaccine Group, International AIDS Vaccine Initiative, Imperial College London - Department of Infectious Disease, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Center for Family Health Research Zambia (CFHRZ), IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme and University of Oxford - The Jenner Institute
Downloads 185 (409,459)

Abstract:

Loading...

T cells, T-cell vaccine, HIV vaccine: conserved regions, phase I trial, HIVconsvX, ChAdOx1, MVA, vaccine safety, vaccine immunogenicity, clinical trial, virus inhibition assay, HIV-1

2.

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

Number of pages: 60 Posted: 19 Feb 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 112 (630,858)
Citation 3

Abstract:

Loading...

Self-amplifying RNA (saRNA) vaccine, SARS-CoV-2 immunogenicity, COVID-19 Vaccination in Africa, Neutralising antibody responses, Spike-specific IgG antibodies, Vaccine safety and reactogenicity, Seronegative vs. seropositive immune response

3.

Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors. Persistent Sequelae in Sudv Survivors after 25 Years

Number of pages: 34 Posted: 28 May 2025
Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, Independent, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 66 (916,100)

Abstract:

Loading...

Sudan ebolavirus, Long-term sequelae, Post EVD syndrome, Ebola survivors, Subclinical dysfunction, Psychosocial resilience, Viral hemorrhagic fever

4.

Saliva PCR Performs Comparably to Lesion Swabs for Acute-Phase Clade Ib Mpox Diagnosis in Uganda: Evidence from a Matched Hospital Cohort

Number of pages: 40 Posted: 03 Dec 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Entebbe Regional Referral Hospital, London School of Hygiene & Tropical Medicine - Uganda Research Unit and Please see PDF for full list of authors & affiliations
Downloads 56 (1,000,027)

Abstract:

Loading...

Mpox, Clade Ib, Saliva, Diagnostic yield, Viral burden, Uganda

5.

Critical Clade Ib Mpox in Adults with HIV in Uganda: A Prospective Observational Study of Viral Burden, Lesion Microbiology, and Inflammatory Markers

Number of pages: 27 Posted: 03 Apr 2026
Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit and Please see PDF for full list of authors & affiliations
Downloads 38 (1,209,354)

Abstract:

Loading...

Mpox, Clade Ib, HIV, Critical illness, Mucocutaneous viral burden, Bacterial superinfection, Antimicrobial resistance, Uganda

6.

Resilience and Residuals Beyond Containment: The Hidden Burden of Bundibugyo Ebola Virus Survivorship Sixteen Years On

Number of pages: 34 Posted: 20 Jun 2025
Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Independent, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI) and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 35 (1,263,436)

Abstract:

Loading...

Bundibugyo ebolavirus, Ebola virus disease survivors, Post-Ebola syndrome, Long-term viral sequelae, Immunometabolic findings, Survivorship care models, Epidemic preparedness

7.

From Training to Activation: A Pass/Fail Framework for Deployable Outbreak Laboratories

Number of pages: 34 Posted: 01 Apr 2026
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Université Catholique de Bukavu, Université Catholique de Bukavu, National Public Health Laboratory, National Public Health Laboratory, National Institute of Public Health, National Institute of Public Health, Coalition for Epidemic Preparedness Innovations, Coalition for Epidemic Preparedness Innovations, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Coalition for Epidemic Preparedness Innovations, University of Queensland - School of Chemistry and Molecular Biosciences and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 33 (1,277,121)

Abstract:

Loading...

Laboratory readiness, Outbreak readiness, Epidemic preparedness, Health systems strengthening, Deployability Framework, Infrastructure, Workforce competency, global health

8.

Lesion Viral Burden, Multidrug-resistant Superinfection and HIV-linked Haematological Vulnerability Define Triage-Relevant Risk in Acute Clade Ib Mpox in Uganda

Posted: 18 Nov 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit and Please see PDF for full list of authors & affiliations

Abstract:

Loading...

Mpox (Clade 1b), Lesion viral load, Antimicrobial resistance, Bacterial superinfection, Complete blood count, C-reactive protein, HIV viraemia, Uganda